Cerebras Systems Inc. · CBRS · FY2026 Q1 · Calendar Q2 2026
Cerebras posts rapid growth while scaling AI inference capacity
The supplied analysis supports a constructive demand case for Cerebras' AI inference platform, but the next phase depends on converting partnerships and reported demand into scalable capacity and improving economics.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about CBRS FY2026 Q1
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
The supplied analysis highlights a record first quarter, rapid cloud-services growth, a newly disclosed multi-year OpenAI compute agreement, and an AWS disaggregated-inference agreement. Management is moving from demand validation toward broader data-center, manufacturing and partner-ecosystem expansion.
Guidance delta
Maintained; the supplied analysis describes continued high growth, with operating margins remaining negative while data-center capacity is scaled.
Key takeaways
- Revenue grew 92% year over year, while cloud services grew 167%, according to the supplied analysis.
- OpenAI and AWS partnerships support demand visibility and broaden Cerebras' inference reach.
- The wafer-scale architecture and SRAM-based design are presented as differentiators for fast AI inference.
- Capacity expansion and negative operating margins remain the main execution constraints.
Management priorities
- Deploy CS-3 systems in new global data centers and expand cloud capacity.
- Launch disaggregated inference solutions with AWS Trainium in the second half of the year.
- Scale manufacturing through Flextronics and Sanmina while adding U.S. clean-room capacity.
- Advance next-generation wafer-scale chips and broaden the partner ecosystem.
Follow CBRS with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wedbush | Outperform | Outperform | Maintain | Nov 9, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 9, 2026 |
| UBS | Buy | Buy | Maintain | Nov 2, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 19, 2026 |
| Freedom Capital Markets | Buy | Hold | Upgrade | Oct 2, 2026 |
| Rosenblatt | Buy | Buy | Maintain | Aug 19, 2026 |
| Needham | Buy | Buy | Maintain | Aug 19, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Aug 13, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 13, 2026 |
Named analyst price targets
Upside is calculated against the persisted current price $82.67. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Vijay Rakesh | $240 | $97.75 | +190.3% | Nov 13, 2026 |
| Needham | Quinn Bolton | $200 | $97.75 | +141.9% | Nov 13, 2026 |
| Wedbush | Matt Bryson | $205 | $97.75 | +148.0% | Nov 13, 2026 |
| Rosenblatt Securities | Kevin Cassidy | $170 | $96.7 | +105.6% | Nov 9, 2026 |
| Wedbush | Matt Bryson | $190 | $89.68 | +129.8% | Nov 9, 2026 |
| Morgan Stanley | Analyst unavailable | $279 | $262.06 | +237.5% | Aug 13, 2026 |
| UBS | Analyst unavailable | $330 | $262.06 | +299.2% | Aug 13, 2026 |
| Mizuho Securities | Analyst unavailable | $310 | $186.75 | +275.0% | Jul 27, 2026 |
| Wedbush | Analyst unavailable | $280 | $196.3 | +238.7% | Jun 24, 2026 |
| Rosenblatt Securities | Kevin Cassidy | $300 | $226.72 | +262.9% | Jun 24, 2026 |
| UBS | Analyst unavailable | $320 | $226.72 | +287.1% | Jun 24, 2026 |
| Morgan Stanley | Analyst unavailable | $273 | $226.72 | +230.2% | Jun 24, 2026 |
| Craig-Hallum | Analyst unavailable | $325 | $237.83 | +293.1% | Jun 8, 2026 |
| Wedbush | Analyst unavailable | $270 | $201.01 | +226.6% | Jun 8, 2026 |
| Needham | Analyst unavailable | $300 | $201.01 | +262.9% | Jun 8, 2026 |
| UBS | Analyst unavailable | $300 | $201.01 | +262.9% | Jun 8, 2026 |
| Morgan Stanley | Joseph Moore | $250 | $201.01 | +202.4% | Jun 8, 2026 |
| Mizuho Securities | Analyst unavailable | $300 | $201.01 | +262.9% | Jun 8, 2026 |
| Barclays | Tom O'Malley | $280 | $201.01 | +238.7% | Jun 8, 2026 |
Track every rating change on CBRS the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCerebras Systems Inc. is a leading innovator in artificial intelligence infrastructure. The company develops and manufactures an advanced AI compute platform, integrating proprietary hardware systems and software. This platform is delivered in rack-mountable units, suitable for deployment in data centers, scaling all the way up to supercomputer-level capabilities. At its core is the groundbreaking Wafer-Scale Engine (WSE), a unique chip that encompasses an entire silicon wafer.…
Historical context
All CBRS earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| BSP Bending Spoons S.p.A. | FY2026 Q3 · Calendar Q4 2026 | — | +6.2% | Bending Spoons raises 2026 outlook as acquisitions and AI productivity lift Q3 |
| INTU Intuit Inc. | FY2027 Q1 · Calendar Q4 2026 | +18.3% | -6.2% | Intuit's Q1 growth held up, while Credit Karma remains a drag |
| ESTC Elastic N.V. | FY2027 Q2 · Calendar Q4 2026 | +16.2% | +2.0% | Elastic accelerates growth and raises outlook as AI offerings expand |
| KEYS Keysight Technologies, Inc. | FY2026 Q4 · Calendar Q4 2026 | +7.1% | -1.5% | Keysight’s record FY2026 sets up growth, with supply constraints still central |
| NTES NetEase, Inc. | FY2026 Q3 · Calendar Q4 2026 | -12.8% | -11.4% | NetEase’s game portfolio remains strong, while attention and monetization risks persist |
| PANW Palo Alto Networks, Inc. | FY2027 Q1 · Calendar Q4 2026 | +8.0% | +5.9% | Palo Alto Networks raises FY27 outlook as AI security demand accelerates |
Latest beats and misses
Who reports nextBeat on EPS
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
- WMGFY2026 Q4 · November 19, 2026+50.9% EPS-0.6% move
Missed on EPS
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
- XPFY2026 Q3 · November 16, 2026-3.0% EPS-2.5% move
Get the CBRS recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-06-25T22:11:00.006764+00:00
- FN2 earnings calendar · 2026-07-29T01:23:15.868211+00:00
- Polygon adjusted daily market bars · 2026-09-24T03:50:53.521715+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-24T03:50:53.519021+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-24. For educational purposes only; not investment advice.